Educational information, not medical advice — ask your doctor or midwife.
PEMF therapy uses a device to deliver short bursts of electromagnetic energy to targeted areas of the body. The pulses pass harmlessly through tissue and are thought to influence cellular activity at the level of ion channels, mitochondria, and cell membranes. It has been FDA-cleared for specific uses like bone fracture healing and surgical fusion since the 1970s, and interest in broader applications has grown steadily since.
The electromagnetic pulses create tiny electrical currents within tissue that mimic the body's own bioelectric signals. This appears to stimulate cellular energy production, encourage the movement of calcium and other ions across cell membranes, reduce inflammatory signaling, and support the natural repair processes in bone and soft tissue. Different frequencies and intensities are used for different goals — lower frequencies tend to be calming and are used for sleep and pain, while higher frequencies are used for bone stimulation.
FDA-cleared clinical devices (like EBI Bone Healing System) are prescribed for non-union fractures and spinal fusion. Consumer-grade full-body mats are popular for general wellness, pain, and sleep. Localized coil or pad applicators are used for targeted joint or muscle treatment. Wearable units are emerging for on-the-go use. Device quality and output parameters vary significantly across brands — this matters for outcomes.
The bioelectric basis of bone healing was discovered in the 1950s–60s by researchers including Dr. Robert Becker and Dr. Andrew Bassett. The first FDA clearance for PEMF bone healing came in 1979. NASA research in the 1990s–2000s explored PEMF for maintaining astronaut bone and muscle mass in zero gravity, and those findings helped broaden interest in wellness applications.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.